ID25784A - Bentuk dosis oral padat yang terdiri dari suatu kombinasi metformin dan glibernclamida - Google Patents

Bentuk dosis oral padat yang terdiri dari suatu kombinasi metformin dan glibernclamida

Info

Publication number
ID25784A
ID25784A IDW20000482D ID20000482D ID25784A ID 25784 A ID25784 A ID 25784A ID W20000482 D IDW20000482 D ID W20000482D ID 20000482 D ID20000482 D ID 20000482D ID 25784 A ID25784 A ID 25784A
Authority
ID
Indonesia
Prior art keywords
glibernclamid
metformin
combination
solid dosage
oral solid
Prior art date
Application number
IDW20000482D
Other languages
English (en)
Indonesian (id)
Inventor
Yves Bonhomme
Geoffrey Nicholson
Gillian Cave
Sarah J Nicholson
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8235441&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID25784(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lipha filed Critical Lipha
Publication of ID25784A publication Critical patent/ID25784A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW20000482D 1998-07-15 1999-07-12 Bentuk dosis oral padat yang terdiri dari suatu kombinasi metformin dan glibernclamida ID25784A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98401781A EP0974356B1 (en) 1998-07-15 1998-07-15 Tablets comprising a combination of metformin and glibenclamide

Publications (1)

Publication Number Publication Date
ID25784A true ID25784A (id) 2000-11-02

Family

ID=8235441

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000482D ID25784A (id) 1998-07-15 1999-07-12 Bentuk dosis oral padat yang terdiri dari suatu kombinasi metformin dan glibernclamida

Country Status (27)

Country Link
US (2) US6303146B1 (ko)
EP (4) EP0974356B1 (ko)
JP (2) JP2002520371A (ko)
KR (2) KR20040053177A (ko)
CN (2) CN1486698A (ko)
AP (1) AP1450A (ko)
AR (2) AR013052A1 (ko)
AT (1) ATE250418T1 (ko)
AU (2) AU753604B2 (ko)
BR (1) BR9906600A (ko)
CA (1) CA2303537C (ko)
DE (1) DE69818444T2 (ko)
DK (1) DK0974356T3 (ko)
DZ (1) DZ2846A1 (ko)
ES (1) ES2206868T3 (ko)
ID (1) ID25784A (ko)
MA (1) MA24930A1 (ko)
MY (1) MY129552A (ko)
NZ (1) NZ503248A (ko)
OA (1) OA11400A (ko)
PT (1) PT974356E (ko)
RU (2) RU2286788C2 (ko)
SI (1) SI0974356T1 (ko)
TW (2) TWI245632B (ko)
UY (1) UY25611A1 (ko)
WO (1) WO2000003742A2 (ko)
ZA (1) ZA200001159B (ko)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
BR0015294A (pt) * 1999-11-03 2003-07-15 Bristol Myers Squibb Co Método para tratamento da diabetes
US20010036479A1 (en) 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
FR2816840B1 (fr) 2000-11-17 2004-04-09 Flamel Tech Sa Medicament a base de microcapsules d'anti-hyperclycemiant a liberation prolongee et son procede de preparation
FR2816841B1 (fr) * 2000-11-22 2004-02-06 Lipha Nouvelles compositions pharmaceutiques a action antidiabetique et leur procede de preparation
WO2002055009A1 (en) * 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
FR2825023B1 (fr) * 2001-05-23 2005-04-15 Flamel Tech Sa Forme pharmaceutique orale antidiabetique "une prise par jour"comprenant une biguanide et au moins un autre principe actif
US7767249B2 (en) * 2001-06-07 2010-08-03 Hewlett-Packard Development Company, L.P. Preparation of nanoparticles
US20050271737A1 (en) * 2001-06-07 2005-12-08 Chinea Vanessa I Application of a bioactive agent to a substrate
US8206753B2 (en) * 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
US7879869B2 (en) 2001-07-30 2011-02-01 Mitsubishi Tanabe Pharma Corporation Drugs for ameliorating postcibal hyperglycemia
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
ITFI20010230A1 (it) * 2001-11-29 2003-05-29 Menarini Int Operations Lu Sa Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii
US7183321B2 (en) * 2001-12-17 2007-02-27 Bristol-Myers Squibb Company Antidiabetic formulation and method
WO2003061643A1 (es) * 2002-01-25 2003-07-31 Laboratorios Silanes, S.A. De C.V. Composicion farmaceutica para el control de la glucosa en sangre de pacientes con diabetes tipo 2
SI1476138T1 (sl) * 2002-02-21 2012-07-31 Valeant Internat Barbados Srl Formulacije s prirejenim sproščanjem vsaj ene oblike tramadola
US20030187074A1 (en) * 2002-03-04 2003-10-02 Javed Hussain Oral compositions for treatment of diabetes
US20030219482A1 (en) * 2002-03-21 2003-11-27 Chaudhari Sunil Sudhakar Multiparticulate compositions for once-a-day administration
MXPA04009979A (es) 2002-04-09 2004-12-13 Flamel Tech Sa Formulacion farmaceutica oral bajo forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de amoxicilina.
CA2480826C (fr) 2002-04-09 2012-02-07 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
US7445796B2 (en) * 2002-08-19 2008-11-04 L. Perrigo Company Pharmaceutically active particles of a monomodal particle size distribution and method
WO2004045622A1 (en) * 2002-11-15 2004-06-03 Ranbaxy Laboratories Limited Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
FR2853831A1 (fr) * 2003-03-05 2004-10-22 Usv Ltd Forme posologique solide a usage oral de metformine et de glyburide et son procede de preparation
WO2004091661A1 (ja) * 2003-04-15 2004-10-28 Chugai Seiyaku Kabushiki Kaisha 糖尿病治療剤
US20060121108A1 (en) * 2004-12-02 2006-06-08 Prasad C K System and method for producing a directly compressible, high-potency formulation of metformin hydrochloride
CN100341495C (zh) * 2004-12-29 2007-10-10 三九医药股份有限公司 格列本脲固体分散体、口服组合物及其制备方法
KR100760430B1 (ko) * 2004-12-31 2007-10-04 한미약품 주식회사 당뇨병 치료제의 경구 투여용 서방성 복합 제제 및 이의제조 방법
PE20061245A1 (es) * 2005-03-30 2007-01-06 Generex Pharm Inc Composiciones para la transmision transmucosa oral de la metformina
US8529537B2 (en) * 2005-08-05 2013-09-10 Kimberly-Clark Worldwide, Inc. Absorbent article with enclosures
MXPA05009633A (es) * 2005-09-08 2007-03-07 Silanes Sa De Cv Lab Composicion farmaceutica estable de glimepirida de liberacion inmediata y metformina de liberacion prolongada.
EP2037928B1 (en) 2006-06-26 2012-01-11 Amgen Inc. Methods for treating atherosclerosis
WO2008062273A2 (en) * 2006-11-20 2008-05-29 Cadila Pharmaceuticals Limited Solid oral dosage form having antidiabetic drug combination
EP2185138B1 (en) 2007-07-19 2016-09-07 Takeda Pharmaceutical Company Limited Solid preparation comprising alogliptin and metformin hydrochloride
EP2489731B1 (en) 2007-07-26 2014-08-27 Amgen, Inc Modified lecithin-cholesterol acyltransferase enzymes
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
US20130108699A1 (en) * 2010-04-26 2013-05-02 Jose Antonio Matji Tuduri Highly dispersible granulate for the preparation of formulations of high dosage active substances and procedure for obtaining high dosage active substances thereof
RU2451506C1 (ru) 2011-06-02 2012-05-27 Сергей Юрьевич Лешков Комбинация для лечения сахарного диабета и его осложнений
JP6635655B2 (ja) 2011-12-08 2020-01-29 アムジエン・インコーポレーテツド ヒトｌｃａｔ抗原結合タンパク質および治療法におけるそれらの使用
CN104127424A (zh) * 2014-07-30 2014-11-05 沈阳药科大学 格列本脲衍生物及其制备方法和应用
CN105030793A (zh) * 2015-08-25 2015-11-11 瑞阳制药有限公司 二甲双胍格列本脲胶囊及其制备方法
WO2019070109A1 (es) * 2017-10-03 2019-04-11 Infinite Clinical Research International, S.A. De C.V. Triconjugado para el tratamiento de diabetes mellitus
KR102484756B1 (ko) * 2020-11-13 2023-01-06 한국생산기술연구원 용해성 증대 및 취급용이성을 갖는 파우더 배지의 과립화 방법
CN113143940A (zh) * 2020-12-30 2021-07-23 成都恒瑞制药有限公司 一种抗糖尿病药物组合物的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE362704C (de) * 1921-08-09 1922-11-02 Naamlooze Vennootschap Interna Vorrichtung zum Senken einer Last, insbesondere eines Rettungsbootes
US3174901A (en) 1963-01-31 1965-03-23 Jan Marcel Didier Aron Samuel Process for the oral treatment of diabetes
US4060634A (en) * 1973-09-26 1977-11-29 Boehringer Mannheim G.M.B.H. Rapidly resorbable glibenclamide
DE2348334C2 (de) 1973-09-26 1982-11-11 Boehringer Mannheim Gmbh, 6800 Mannheim Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs
US4916163A (en) 1985-06-04 1990-04-10 The Upjohn Company Spray-dried lactose formulation of micronized glyburide
DE3833439A1 (de) 1988-10-01 1991-09-12 Hoechst Ag Verfahren zur mikronisierung von glibenclamid
DK36392D0 (da) 1992-03-19 1992-03-19 Novo Nordisk As Anvendelse af kemisk forbindelse
DE4323636A1 (de) 1993-07-15 1995-01-19 Hoechst Ag Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
TW438587B (en) 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
IT1276130B1 (it) * 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
WO1998057634A1 (en) 1997-06-18 1998-12-23 Smithkline Beecham Plc Treatment of diabetes with thiazolidinedione and metformin
US6544564B1 (en) * 2001-11-27 2003-04-08 Michael Donald Farley Cytotoxic pharmaceutical composition

Also Published As

Publication number Publication date
JP2003292443A (ja) 2003-10-15
EP0974356A1 (en) 2000-01-26
DZ2846A1 (fr) 2003-12-01
RU2286788C2 (ru) 2006-11-10
CN1146427C (zh) 2004-04-21
EP1011684A2 (en) 2000-06-28
SI0974356T1 (en) 2003-12-31
EP2269613A3 (en) 2012-10-17
AU2003261560A1 (en) 2005-05-26
WO2000003742A3 (en) 2000-04-20
USRE38629E1 (en) 2004-10-19
MY129552A (en) 2007-04-30
AU753604B2 (en) 2002-10-24
EP1435240A3 (en) 2009-08-12
US6303146B1 (en) 2001-10-16
AP1450A (en) 2005-07-25
DE69818444T2 (de) 2004-05-06
TW555560B (en) 2003-10-01
KR20040053177A (ko) 2004-06-23
ZA200001159B (en) 2001-05-31
KR100478347B1 (ko) 2005-03-23
OA11400A (en) 2004-04-08
AR013052A1 (es) 2000-11-22
EP0974356B1 (en) 2003-09-24
ES2206868T3 (es) 2004-05-16
MA24930A1 (fr) 2000-04-01
PT974356E (pt) 2004-02-27
EP2269613A2 (en) 2011-01-05
DK0974356T3 (da) 2003-10-27
AP2000001757A0 (en) 2000-03-31
AR065970A2 (es) 2009-07-15
EP1435240A2 (en) 2004-07-07
JP2002520371A (ja) 2002-07-09
TW200303208A (en) 2003-09-01
AU5417999A (en) 2000-02-07
WO2000003742A2 (en) 2000-01-27
RU2003126257A (ru) 2005-02-27
CN1275082A (zh) 2000-11-29
DE69818444D1 (de) 2003-10-30
CA2303537C (en) 2005-12-06
NZ503248A (en) 2002-09-27
ATE250418T1 (de) 2003-10-15
BR9906600A (pt) 2000-07-18
CN1486698A (zh) 2004-04-07
RU2226396C2 (ru) 2004-04-10
TWI245632B (en) 2005-12-21
CA2303537A1 (en) 2000-01-27
UY25611A1 (es) 2000-08-21
KR20010030603A (ko) 2001-04-16

Similar Documents

Publication Publication Date Title
ID25784A (id) Bentuk dosis oral padat yang terdiri dari suatu kombinasi metformin dan glibernclamida
ID17553A (id) Bentuk-bentuk padatan dosis oral
HK1045655A1 (zh) 由二甲雙胍及伏降糖組合構成的藥劑成份
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
FI963984A (fi) Uusi oraalinen farmaseuttinen annostelumuoto
ATE415149T1 (de) Dosierungsform eines pulveragglomerates
ID28109A (id) Benda-benda absorben yang terdiri dari suatu bahan yang mempunyai kemampuan fluks yang tinggi
HUP9902092A3 (en) Metalloproteinase inhibitor benzenesulfonamide derivatives, intermediates, preparation and use thereof, pharmaceutical compositions containing these compounds
ID26022A (id) Bentuk galenic pelepasan yang telah diperpanjang dan pelepasan lanjutan yang terdiri dari bahan peningkat absorpsi yang dapat diberikan melalui mulut dan penggunaan bahan peningkat absorpsi tersebut
PL341428A1 (en) Oral pharmacological dosage form of prolonged release type
ATE284695T1 (de) Oral anzuwendende arzneizusammensetzung enthaltend 2-methyl-thienobenzodiazepin
EE9900533A (et) Budesoniidi peenestatud kristallilisi osakesi sisaldav ravimvorm
NO20001914D0 (no) <alfa>-Aryl-N-alkylnitroner og farmasøytiske blandinger som inneholder slike
ID27728A (id) Komposisi-komposisi mukoadesif oral yang mengandung bahan-bahan aktif gastrointestinal
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
FI970058A0 (fi) Uusi suun kautta annettava farmaseuttinen valmiste, joka sisältää omepratsolin magnesiumsuolaa
ID26040A (id) Komposisi katalitik yang terdiri dari senyawa titanium, senyawa amina fosfor; pembuatan dan penggunaannya
DE69900823D1 (de) Injizierbare arzneizubereitung bestehend aus paracetamol
PL340456A1 (en) Novel oral dosage form of carvedilol
HUP0104420A2 (en) Therapeutic composition containing a new form of tramadol and its use
DE69812962D1 (de) Oral anzuwendende Arzneizubereitung enthaltend S-(3-Hydroxypropyl)-L-Cystein
DE69825193D1 (de) Pyridazinon-Verbindungen enthaltenden Zusammensetzungen zur oralen Verabreichung
NO981320D0 (no) Oral anvendelse av (+)-O-demetyltramadol som smertemiddel
GB0404741D0 (en) A solid oral dosage form of metformin and glyburide and the method of preparation thereof